These Analysts Revise Their Forecasts On GH Research After Q1 Results

Benzinga05-15

GH Research PLC (NASDAQ:GHRS) reported a wider-than-expected loss for the first quarter on Thursday.

The company posted quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 28 cents per share.

“The first quarter of 2026 marks progress as planned toward our global GH001 Phase 3 pivotal program,” said Dr. Velichka Valcheva, Chief Executive Officer.

GH Research shares fell 3.4% to trade at $21.46 on Friday.

These analysts made changes to their price targets on GH Research following earnings announcement.

Citizens analyst Jason N. Butler maintained GH Research with a Market Outperform and lowered the price target from $42 to $39.
Cantor Fitzgerald analyst Charles Duncan maintained the stock with an Overweight rating and raised the price target from $25 to $35.

Considering buying GHRS stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2635035358?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-15 22:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635035358","market":"us","top_or_hot":-1,"title":"These Analysts Revise Their Forecasts On GH Research After Q1 Results","media":"Benzinga","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/GHRS\">GH Research PLC</a></strong> (NASDAQ:GHRS) reported a wider-than-expected loss for the first quarter on Thursday.</p>\n<p>The company posted quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 28 cents per share.</p>\n<p>“The first quarter of 2026 marks progress as planned toward our global GH001 Phase 3 pivotal program,” said Dr. Velichka Valcheva, Chief Executive Officer.</p>\n<p>GH Research shares fell 3.4% to trade at $21.46 on Friday.</p>\n<p>These analysts made changes to their price targets on GH Research following earnings announcement.</p>\n<ul>\n<li>Citizens analyst Jason N. Butler maintained GH Research with a Market Outperform and lowered the price target from $42 to $39.</li>\n<li>Cantor Fitzgerald analyst Charles Duncan maintained the stock with an Overweight rating and raised the price target from $25 to $35.</li>\n</ul>\n<p><strong>Considering buying GHRS stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"435\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-1024x435.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-1024x435.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-300x128.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-768x327.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421.png 1277w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These Analysts Revise Their Forecasts On GH Research After Q1 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese Analysts Revise Their Forecasts On GH Research After Q1 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2026-05-15 22:58</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong><a href=\"https://laohu8.com/S/GHRS\">GH Research PLC</a></strong> (NASDAQ:GHRS) reported a wider-than-expected loss for the first quarter on Thursday.</p>\n<p>The company posted quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 28 cents per share.</p>\n<p>“The first quarter of 2026 marks progress as planned toward our global GH001 Phase 3 pivotal program,” said Dr. Velichka Valcheva, Chief Executive Officer.</p>\n<p>GH Research shares fell 3.4% to trade at $21.46 on Friday.</p>\n<p>These analysts made changes to their price targets on GH Research following earnings announcement.</p>\n<ul>\n<li>Citizens analyst Jason N. Butler maintained GH Research with a Market Outperform and lowered the price target from $42 to $39.</li>\n<li>Cantor Fitzgerald analyst Charles Duncan maintained the stock with an Overweight rating and raised the price target from $25 to $35.</li>\n</ul>\n<p><strong>Considering buying GHRS stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"435\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-1024x435.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-1024x435.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-300x128.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421-768x327.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/15105718/image-421.png 1277w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/05/52601688/these-analysts-revise-their-forecasts-on-gh-research-after-q1-results","article_id":"2635035358","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2635035358","pubTimestamp":1778857103,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"GH Research (NASDAQ:GHRS) reported a larger loss than expected in Q1. Analysts lowered price targets, stock fell 3.4%. CEO noted progress in GH001 program.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","GH":"Guardant Health Inc.","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓","BK4196":"保健护理服务","BK4585":"ETF&股票定投概念","BK4539":"次新股","GHRS":"GH Research PLC","BK4588":"碎股"},"translate_title":"这些分析师在第一季度业绩公布后修改了对GH Research的预测","themeId":"11c8fbbf839f433c9d274cef5f173382","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GH":1.5,"GHRS":1},"content_text":"GH Research PLC (NASDAQ:GHRS) reported a wider-than-expected loss for the first quarter on Thursday.\nThe company posted quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 28 cents per share.\n“The first quarter of 2026 marks progress as planned toward our global GH001 Phase 3 pivotal program,” said Dr. Velichka Valcheva, Chief Executive Officer.\nGH Research shares fell 3.4% to trade at $21.46 on Friday.\nThese analysts made changes to their price targets on GH Research following earnings announcement.\n\nCitizens analyst Jason N. Butler maintained GH Research with a Market Outperform and lowered the price target from $42 to $39.\nCantor Fitzgerald analyst Charles Duncan maintained the stock with an Overweight rating and raised the price target from $25 to $35.\n\nConsidering buying GHRS stock? Here’s what analysts think:\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2635035358","isCrawlerRequest":true}